Recordati Industria Chimica e Farmaceutica SpA 2025 IR
The report highlights Recordati's strong performance in 2025, delivering double-digit revenue growth of 11.8% to €2,618.4 million and a 14.5% increase in EBITDA. The company expanded its rare diseases portfolio with the integration of Enjaymo and signed a licensing agreement for Vazkepa in Europe. On the sustainability front, Recordati completed the installation of solar panels in Tunisia, Italy, and Spain, reaching a total installed capacity of approximately 6,200 kWp. Additionally, the company achieved ISO 14001 certification for all its chemical-pharmaceutical plants and ISO 50001 for its Tunisian site.
Company: Recordati Industria Chimica e Farmaceutica SpA
Sector: Manufacturing
Country: Italy
Year: 2025
Type: IR
Pages: 372
Back to company
Recordati Industria Chimica e Farmaceutica SpA
Integrated Consolidated Financial Statements
The report highlights Recordati's strong performance in 2025, delivering double-digit revenue growth of 11.8% to €2,618.4 million and a 14.5% increase in EBITDA. The company expanded its rare diseases portfolio with the integration of Enjaymo and signed a licensing agreement for Vazkepa in Europe. On the sustainability front, Recordati completed the installation of solar panels in Tunisia, Italy, and Spain, reaching a total installed capacity of approximately 6,200 kWp. Additionally, the company achieved ISO 14001 certification for all its chemical-pharmaceutical plants and ISO 50001 for its Tunisian site.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees